Proteus mirabilis RMS 203 as a new representative of the O13 Proteus serogroup

• Authors: Agata Palusiak , Małgorzata Siwińska , Agnieszka Zabłotni
• Languages of publication: EN

Abstracts

EN

The unique feature of some Proteus O-polysaccharides is occurrence of an amide of galacturonic acid with Nε-[(S/R)-1-Carboxyethyl]-l-lysine, GalA6(2S,8S/R-AlaLys). The results of the serological studies presented here, with reference to known O-antigens structures suggest that GalA6(2S,8S/R-AlaLys) or 2S,8R-AlaLys contribute to cross-reactions of O13 Proteus antisera, and Proteeae LPSs. It was also revealed that the Proteus mirabilis RMS 203 strain can be classified into the O13 serogroup, represented so far by two strains: Proteus mirabilis 26/57 and Proteus vulgaris 8344. The O13 LPS is a serologically important antigen with a fragment common to LPSs of different species in the Proteeae tribe.

Keywords

EN

cross-reaction; lipopolysaccharide; O-polysaccharide; O serogroup; Proteus

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2015
• Volume: 62
• Issue: 4
• Pages: 691-695

Dates

published

2015

received

2015-07-15

revised

2015-09-30

accepted

2015-10-30

(unknown)

2015-12-08

Contributors

author

Agata Palusiak

• Department of General Microbiology, Institute of Microbiology, Biotechnology and Immunology, University of Łódź, Łódź, Poland

author

Małgorzata Siwińska

• Department of General Microbiology, Institute of Microbiology, Biotechnology and Immunology, University of Łódź, Łódź, Poland

author

Agnieszka Zabłotni

• Department of General Microbiology, Institute of Microbiology, Biotechnology and Immunology, University of Łódź, Łódź, Poland

References

• Armbruster CE, Mobley HL (2012) Merging mythology and morphology: the multifaceted life style of Proteus mirabilis. Nat Rev Microbiol 10: 743-754.
• Bartodziejska B, Radziejewska-Lebrecht J, Lipinska M, Knirel YA, Kononov LO, Chernyak AY, Mayer H, Rozalski A (1996) Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959. FEMS Immunol Med Microbiol 13: 113-121.
• Coker C, Poore CA, Li X, Mobley HL (2000) Pathogenesis of Proteus mirabilis urinary tract infections. Microbes Infect 2: 1497-1505.
• Drzewiecka D, Arbatsky NP, Shashkov AS, Stączek P, Knirel YA, Sidorczyk Z (2008) Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup. FEMS Immunol Med Microbiol 54: 185-194.
• Kaca W, Glenska J, Lechowicz L, Grabowski S, Brauner A, Kwinkowski M (2011) Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures. Biochemistry (Mosc) 76: 851-861.
• Knirel YA, Perepelov AV, Kondakova AN, Senchenkova SN, Sidorczyk Z, Rozalski A, Kaca W (2011) Structure and serology of O-antigens as the basis for classification of Proteus strains. Innate Immunity 17: 70-96.
• Kocharova NA, Zatonsky GV, Torzewska A, Macieja Z, Bystrova OV, Shashkov AS, Knirel YA, Rozalski (2003) Structure of the O-specific polysaccharide of Providencia rustigianii O14 containing Nε-[(S)-1-carboxyethyl]-Nα-(d-galacturonoyl)-l-lysine. Carbohydr Res 338: 1009-1016.
• Larsson P, (1984) Serology of Proteus mirabilis and Proteus vulgaris. In Methods Microbiol. Bergan T ed, pp 187-214. Academic Press INC, London.
• O'Hara CM, Brenner FW, Miller JM (2000) Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 13: 534-546.
• Penner JL, (1992) The genera Proteus, Providencia and Morganella. In The Prokaryotes. Balows A, Truper HG, Harder W, Schleiger KH eds, pp 2849-2853. Springer, Berlin.
• Palusiak A, Maciejewska A, Ługowski C, Różalski A (2014) The amide of galacturonic acid with lysine as an immunodominant component of the lipopolysaccharide core region from Proteus penneri 42 strain. Acta Biochim Pol 61: 129-132.
• Palusiak A, Siwińska M, Sidorczyk Z (2013) Serological studies of Proteus penneri strains determining qualification to appropriate O-serogroup. Pol J Microbiol 62: 211-216.
• Radziejewska-Lebrecht J, Shashkov AS, Vinogradov EV, Grosskurth H, Bartodziejska B, Rozalski A, Kaca W, Kononov LO, Chernyak AY, Mayer H, Knirel YA, Kochetkov NK (1995) Structure and epitope characterisation of the O-specific polysaccharide of Proteus mirabilis O28 containing amides of d-galacturonic acid with l-serine and l-lysine. Eur J Biochem 230: 705-712.
• Różalski A, Sidorczyk Z, Kotełko K (1997) Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev 61: 65-89.
• Różalski A, Torzewska A, Moryl M, Kwil I, Maszewska A, Ostrowska K, Drzewiecka D, Zabłotni A, Palusiak A, Siwińska M, Stączek P (2012) Proteus sp. - an opportunistic bacterial pathogen - classification, swarming growth, clinical significance and virulence factors. Folia Biologica et Oecologica 8: 1-17.
• Shashkov AS, Toukach FV, Senchenkova SN, Ziolkowski A, Paramonov NA, Kaca W, Knirel YA, Kochetkov NK (1997) Structure of the O-specific polysaccharide of the bacterium Proteus mirabilis O13 containing a novel component: an amide of d-galacturonic acid with Nε-(1-carboxyethyl)lysine. Biochemistry (Mosc) 62: 509-513.
• Sidorczyk Z, Kondakova AN, Zych K, Senchenkova SN, Shashkov AS, Drzewiecka D, Knirel YA (2003) Structure of the O-polysaccharide from Proteus myxofaciens. Classification of the bacterium into a new Proteus-O-serogroup. Eur J Biochem 270: 3182-3188.
• Sidorczyk Z, Zych K, Toukach FV, Arbatsky NP, Zablotni A, Shashkov AS, Knirel YA (2002) Structure of the O-polysaccharide and classification of Proteus mirabilis strain G1 in Proteus serogroup O3. Eur J Biochem 269: 1406-1412.
• Siwińska M, Levina EA, Ovchinnikova OG, Drzewiecka D, Shashkov AS, Różalski A, Knirel YA (2015) Classification of a Proteus penneri clinical isolate with a unique O-antigen structure to a new Proteus serogroup, O80. Carbohydr Res 407: 131-136.
• Torzewska A, Budzyńska A, Białczak-Kokot M, Różalski A (2014) In vitro studies of epithelium-associated crystallization caused by uropathogens during urinary calculi development. Microb Pathog 71-72: 25-31.
• Westphal O, Jann K (1965) Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 5: 83-91.
• Zych K, Siwińska M, Sidorczyk Z (2005) Serological classification and epitope specificity of Proteus penneri S29 lipopolysacharide. Arch Immunol Ther Exp (Warsz)53: 540-545.
• Zych K, Kołodziejska K, Drzewiecka D, Perepelov AV, Knirel YA, Sidorczyk Z (2007) Serological classification and epitope specificity of Proteus vulgaris TG 251 from Proteus serogroup O65. Arch Immunol Ther Exp (Warsz) 55: 187-191.

Identifiers

DOI

10.18388/abp.2015_1108